SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at the 12th Annual BIO CEO & Investor Conference on Monday, February 8th, at 11:30 a.m. ET at the Waldorf=Astoria in New York, New York.
